Histologic evaluation of a stem cell-based sinus-augmentation procedure

Journal of Periodontology

Volumn 80, Issue 4, 2009, Pages 679-686

  McAllister, Bradley S ^a   Haghlghat, Kamran ^a,c   Gonshor, Aron ^b  

^a Private Practice   (United States)

^b Private Practice of Orthodontics   (Canada)

^c NONE   (United States)

Author keywords

Bone regeneration; Case series; Osteoblasts; Ridge augmentation; Stem cells; Tissue engineering

Indexed keywords

EID: 63849120043     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2009.080345     Document Type: Article

References (50)

1. Becker W, Becker BE, Caffesse R, A comparison of demlnerallzed freeze-dried bone and autologous bone to induce bone formation in human extraction sockets. J Periodontol 1994;65:1128-1133.
2. Berglundh HT, Lindhe J, Healing around implants placed in bone defects treated with Bio-Oss. An experimental study in the dog. Clin Oral Implants Res 1997;8:117-124.
3. Beaumont C, Schmidt RJ, Tatakis DN, Zafiropoulos GG. Ose of engineered bone for sinus augmentation. J Periodontol 2008;79:541 -548.
4. Schmelzeisen R, Schimming R, Sittinger M. Making bone: Implant insertion into tissue-engineered bone for maxillary sinus floor augmentation - A preliminary report. J Cranlomaxlllofac Surg 2003;31:34-39.
5. Turhani D, Watzinger E, Weissenbock M, et al. Three-dimensional composites manufactured with human mesenchymal cambial layer precursor cells as an alternative for sinus floor augmentation: An in vitro study. Clin Oral Implants Res 2005;16:417-424.
6. Zizelmann C, Schoen R, Metzger MC, et al. Bone formation after sinus augmentation with engineered bone. Clin Oral Implants Res 2007;18:89-73.
7. McAllister BS, Haghighat K. Bone augmentation techniques. J Periodontol 2007;78:377-396.
8. Younger EM, Chapman MW. Morbidity at bone graft donor sites. J Orthop Trauma 1989;3:192-195.
9. Hollinger JO, Brekke J, Gruskin E, Lee D. Role of bone substitutes. Clin Orthop Relat Res 1998;(324):55-65.
10. Holmes RE, Bucholz RW, Mooney V. Porous hydrox-yapatite as a bone graft substitute in diaphyseal defects: A histometric study. J Orthop Res 1987;5:114-121.
11. Einhorn TA, Lane JM, Burstein AH, Kopman CR, Vigorita VJ. The healing of segmental bone defects induced by demineralized bone matrix. A radiographic and biomechanical study. J Bone Joint Surg Am 1984;66:274-279.
12. Margolin MD, Cogan AG, Taylor M, et al. Maxillary sinus augmentation in the non-human primate: A comparative radiographic and histologic study between recombinant human osteogenic protein-1 and natural bone mineral. J Periodontol 1998;89:911-919.
13. Wozney JM, Rosen V. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop Relat Res 1998; (346):26-37.
14. Muschler GF, Nakamoto C, Griffith LG. Engineering principles of clinical cell-based tissue engineering. J Bone Joint Surg Am 2004;86-A: 1541 -1558.
15. Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 2004; 95:9-20.
16. Yoo JO, Barthel TS, Nishimura K, et al. The chondro-genic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg Am 1998;80:1745-1757.
17. Bruder SP, Kraus KH, Goldberg VM, Kadiyala S. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J Bone Joint Surg Am 1998;80:985-998.
18. Bruder SP, Horowitz MC, Mosca JD, Haynesworth SE. Monoclonal antibodies reactive with human osteogenic cell surface antigens. Bone 1997;21:225-235.
19. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-1147.
20. Kadiyala S, Young RG, Thiede MA, Bruder SP. Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. Cell Transplant 1997;6:125-134.
21. Malekzadeh R, Hollinger JO, Buck D, Adams DF, McAllister BS. Isolation of human osteoblast-like cells and in vitro amplification for tissue engineering. J Periodontol 1998;69:1258-1282.
22. Arinzeh TL, Peter SJ, Archambault MP, et al. Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect. J Bone Joint Surg Am 2003;85-A:1927-1935.
23. Bruder SP, Fink DJ, Caplan Al. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem 1994;56:283-294.
24. Bruder SP, Jaiswal N, Ricalton NS, Mosca JD, Kraus KH, Kadiyala S. Mesenchymal stem cells in osteobi-ology and applied bone regeneration. Clin Orthop Relat Res 1998;(355, Suppl.)S247-S256.
25. Bruder SP, Kurth AA, Shea M, Hayes WC, Jaiswal N, Kadiyala S. Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J Orthop Res 1998;16:155-162.
26. De Kok IJ, Peter SJ, Archambault M, et al. Investigation of allogeneic mesenchymal stem cell-based alveolar bone formation: Preliminary findings. Clin Oral Implants Res 2003;14:481-489.
27. Stevenson S, Cunningham N, Toth J, Davy D, Reddi AH. The effect of osteogenin (a bone morphogenetic protein) on the formation of bone in orthotopic segmental defects in rats. J Bone Joint Surg Am 1994; 76:1676-1687.
28. Wallace SS, Froum SJ. Effect of maxillary sinus augmentation on the survival of endosseous dental implants. A systematic review. Ann Periodontol 2003; 8:328-343.
29. Del Fabbro M, Testori T, Francetti L, Weinstein R. Systematic review of survival rates for implants placed in the grafted maxillary sinus. Int J Periodontics Restorative Dent 2004;24:565-577.
30. McAllister BS, Margolin MD, Cogan AG, Taylor M, Wollins J. Residual lateral wall defects following sinus grafting with recombinant human osteogenic protein-1 or Bio-Oss in the chimpanzee. Int J Periodontics Restor-ative Dent 1998;18:227-239.
31. Wheeler SL, Holmes RE, Calhoun CJ. Six-year clinical and histologic study of sinus-lift grafts. Int J Oral Maxillofac Implants 1996;11:26-34.
32. Pittenger MF, Mackay AM, Beck SC, et al, Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
33. Smiler D, Soltan M, Albitar M. Toward the identification of mesenchymal stem cells in bone marrow and peripheral blood for bone regeneration. Implant Dent 2008;17:236-247.
34. Strober W. Trypan blue exclusion test of cell viability. Curr Protoc Immunol 2001; Appendix 3:Appendix 3B.
35. Boyan BD, Bonewald LF, Paschalis EP, et al. Osteoblast-mediated mineral deposition in culture is dependent on surface microtopography, Calcif Tissue Int 2002; 71:519-529.
36. Donath K, Breuner G. A method for the study of undecalcified bones and teeth with attached soft tissues. The Sage-Schliff (sawing and grinding) technique. J Oral Pathol 1982;11:318-326.
37. Rohrer MD, Schubert CC. The cutting-grinding technique for histologic preparation of undecalcified bone and bone-anchored implants. Improvements in instrumentation and procedures. Oral Surg Oral Med Oral Pathol 1992;74:73-78.
38. McAllister BS, Haghighat K, Prasad HS, Rohrer MD. The use of rhPDGF-BB in extraction socket defects: A case series. Int J Periodontics Restorative Dent 2009; in press.
39. Simion M, Rocchietta I, Kim D, Nevins M, Fiorellini J. Vertical ridge augmentation by means of deproteinized bovine bone block and recombinant human platelet-derived growth factor-BB: A histologic study in a dog model. Int J Periodontics Restorative Dent 2006;
40. Boyne PJ, Lilly LC, Marx RE, et al. De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation. J Oral Maxlllofac Surg 2005;63:1693-1707.
41. Fiorellini JP, Howell TH, Cochran D, et al. Randomized study evaluating recombinant human bone morphogenetic protein-2 for extraction socket augmentation. J Periodontal 2005;76:605-613.
42. Wallace SS, Froum SJ, Tarnow DP. Histologic evaluation of a sinus elevation procedure: A clinical report. Int J Periodontics Restorative Dent 1996;16:46-51.
43. -El
44. McLain RF, Fleming JE, Boehm CA, Muschler OF. Aspiration of osteoprogenitor cells for augmenting spinal fusion: Comparison of progenitor cell concentrations from the vertebral body and iliac crest. J Bone Joint Surg Am 2005;87:2655-2661.
45. Muschler GF, Nitto H, Boehm CA, Easley KA. Age-and gender-related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors. J Orthop Res 2001;19:117-125.
46. Lane JM, Yasko AW, Tomin E, et al. Bone marrow and recombinant human bone morphogenetic protein-2 in osseous repair. Clin Orthop Relat Res 1999;361:216-227.
47. Deans RJ, Moseley AB. Mesenchymal stem cells: Biology and potential clinical uses. Exp Hematol 2000:28: 875-884.
48. Haynesworth SE, Goshima J, Goldberg VM, Caplan AI. Characterization of cells with osteogenic potential from human marrow. Bone 1992;13:81-88.
49. Klyushnenkova E, Mosca JD, Zernetkina V, et al. T cell responses to allogeneic human mesenchymal stem cells: Immunogenicity, tolerance, and suppression. J Biomed Sci 2005;12:47-57.
50. Tse WT, Pendleton JD, Beyer WM, Egalka MC, Giuinan EC. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: Implications in transplantation..Transplantation 2003;75:389-397.